OTCMKTS:YECO

EV Biologics News Headlines

$3.50
0.00 (0.00 %)
(As of 08/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.50
$3.50
50-Day Range
$3.00
$4.98
52-Week Range
$0.10
$6.37
Volume404 shs
Average Volume3,093 shs
Market Capitalization$22.49 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.27

EV Biologics (OTCMKTS YECO) News Headlines Today

SourceHeadline
EV Biologics Corporation: EV Biologics NFT Dividend Warrant DateEV Biologics Corporation: EV Biologics NFT Dividend Warrant Date
finanznachrichten.de - July 30 at 9:13 AM
EV Biologics NFT Dividend Warrant DateEV Biologics NFT Dividend Warrant Date
finance.yahoo.com - July 30 at 9:13 AM
EV Biologics Corporation: EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio ServicesEV Biologics Corporation: EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services
finanznachrichten.de - July 28 at 9:22 AM
EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio ServicesEV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services
finance.yahoo.com - July 28 at 9:22 AM
EV Biologics Corporation: EV Biologics Unveils NFT Dividend WarrantEV Biologics Corporation: EV Biologics Unveils NFT Dividend Warrant
finanznachrichten.de - July 26 at 9:53 AM
EV Biologics Unveils NFT Dividend WarrantEV Biologics Unveils NFT Dividend Warrant
finance.yahoo.com - July 26 at 9:53 AM
EV Biologics Corporation: EV Biologics Signs LOI with Lonza Cell & Gene TherapyEV Biologics Corporation: EV Biologics Signs LOI with Lonza Cell & Gene Therapy
finanznachrichten.de - July 24 at 10:06 PM
EV Biologics NFT Dividend UpdateEV Biologics NFT Dividend Update
finance.yahoo.com - July 19 at 12:37 PM
EV Biologics Corporation: EV Biologics Announces NFT DividendEV Biologics Corporation: EV Biologics Announces NFT Dividend
finanznachrichten.de - July 14 at 9:00 AM
EV Biologics Announces NFT DividendEV Biologics Announces NFT Dividend
finance.yahoo.com - July 14 at 8:59 AM
EV Biologics Corporation: EV Biologics is now Pink CurrentEV Biologics Corporation: EV Biologics is now Pink Current
finanznachrichten.de - June 14 at 10:06 AM
EV Biologics is now Pink CurrentEV Biologics is now Pink Current
finance.yahoo.com - June 14 at 10:06 AM
EV Biologics Corporation: EV Biologics Updates Shareholders on Name and Symbol ChangeEV Biologics Corporation: EV Biologics Updates Shareholders on Name and Symbol Change
finanznachrichten.de - May 19 at 1:24 PM
EV Biologics Updates Shareholders on Name and Symbol ChangeEV Biologics Updates Shareholders on Name and Symbol Change
finance.yahoo.com - May 19 at 1:24 PM
EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome ResearchEV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research
finance.yahoo.com - April 8 at 12:46 PM
EV Biologics Corporation: EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome ResearchEV Biologics Corporation: EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research
finanznachrichten.de - April 8 at 9:45 AM
EV Biologics Corporation: EV Biologics Designs Process for Scalable Exosome Biopharmaceutical ManufacturingEV Biologics Corporation: EV Biologics Designs Process for Scalable Exosome Biopharmaceutical Manufacturing
finanznachrichten.de - February 22 at 1:36 PM
EV Biologics Designs Process for Scalable Exosome Biopharmaceutical ManufacturingEV Biologics Designs Process for Scalable Exosome Biopharmaceutical Manufacturing
finance.yahoo.com - February 22 at 1:36 PM
EV Biologics Corporation: EV Biologics Has Engaged Foley & Lardner LLP for Legal Counsel in Intellectual PropertyEV Biologics Corporation: EV Biologics Has Engaged Foley & Lardner LLP for Legal Counsel in Intellectual Property
finanznachrichten.de - January 26 at 8:45 AM
EV Biologics Has Engaged Foley & Lardner LLP for Legal Counsel in Intellectual PropertyEV Biologics Has Engaged Foley & Lardner LLP for Legal Counsel in Intellectual Property
finance.yahoo.com - January 26 at 8:45 AM
EV Biologics Corporation: EV Biologics Update for 2021EV Biologics Corporation: EV Biologics Update for 2021
finanznachrichten.de - January 4 at 9:32 AM
EV Biologics Update for 2021EV Biologics Update for 2021
finance.yahoo.com - January 4 at 9:32 AM
EV Biologics Corporation: EV Biologics Signs Funding Agreement for Biotech Security Token OfferingEV Biologics Corporation: EV Biologics Signs Funding Agreement for Biotech Security Token Offering
finanznachrichten.de - December 3 at 8:31 PM
EV Biologics Signs Funding Agreement for Biotech Security Token OfferingEV Biologics Signs Funding Agreement for Biotech Security Token Offering
finance.yahoo.com - December 2 at 2:28 PM
EV Biologics is Targeting Pink CurrentEV Biologics is Targeting Pink Current
finance.yahoo.com - November 10 at 10:28 AM
Yulong Eco-Materials Limited: Yulong to List its Securitized Token on CryptoSXYulong Eco-Materials Limited: Yulong to List its Securitized Token on CryptoSX
finanznachrichten.de - September 23 at 12:18 PM
Yulong to List its Securitized Token on CryptoSXYulong to List its Securitized Token on CryptoSX
finance.yahoo.com - September 23 at 12:18 PM
Yulong Eco-Materials Limited: Yulong to Issue the Worlds First Biotech Securitized Token OfferingYulong Eco-Materials Limited: Yulong to Issue the Worlds' First Biotech Securitized Token Offering
finanznachrichten.de - September 22 at 12:37 AM
Yulong to Issue the Worlds’ First Biotech Securitized Token OfferingYulong to Issue the Worlds’ First Biotech Securitized Token Offering
finance.yahoo.com - September 21 at 9:35 AM
Yulong Selects Nashville Area to Develop Cellular Biological DrugsYulong Selects Nashville Area to Develop Cellular Biological Drugs
finance.yahoo.com - September 14 at 12:52 PM
Yulong Intends to Develop a Cell Biologics Incubator LabYulong Intends to Develop a Cell Biologics Incubator Lab
finance.yahoo.com - September 9 at 12:14 PM
Yulong Recruits Dr. Jason Sanders as CMOYulong Recruits Dr. Jason Sanders as CMO
finance.yahoo.com - August 31 at 10:00 AM
Yulong Eco-Materials Limited: Yulong Changes Name to EV BiologicsYulong Eco-Materials Limited: Yulong Changes Name to EV Biologics
finanznachrichten.de - August 6 at 9:49 AM
Yulong Changes Name to EV BiologicsYulong Changes Name to EV Biologics
finance.yahoo.com - August 6 at 9:49 AM
Yulong Signs Agreement to Acquire Michelangelo’s Crucifixion MasterpieceYulong Signs Agreement to Acquire Michelangelo’s Crucifixion Masterpiece
www.bloomberg.com - July 23 at 12:08 AM
Yulong Eco-Materials (YECO) Gains Nearly 50% After Acquiring Michelangelos Crucifixion MasterpieceYulong Eco-Materials (YECO) Gains Nearly 50% After Acquiring Michelangelo's Crucifixion Masterpiece
www.streetinsider.com - December 14 at 9:33 AM
Yulong Eco-Materials (YECO) Reports NASDAQ Delisting at Open on Dec. 14Yulong Eco-Materials (YECO) Reports NASDAQ Delisting at Open on Dec. 14
www.streetinsider.com - December 14 at 9:33 AM
Yulong Eco-Materials Limited Announces NASDAQ DelistingYulong Eco-Materials Limited Announces NASDAQ Delisting
finance.yahoo.com - December 14 at 9:33 AM
Yulong buys Michelangelos crucifixion masterpieceYulong buys Michelangelo's crucifixion masterpiece
seekingalpha.com - December 13 at 9:08 AM
Yulong Acquires Michelangelo’s Crucifixion MasterpieceYulong Acquires Michelangelo’s Crucifixion Masterpiece
finance.yahoo.com - December 13 at 9:08 AM
This page was last updated on 8/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.